CooperCompanies stock stays centered on its core medical devices business
Published on 07/04/2026 at 12:00 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS
By Christina Vaughn, Background & Management desk. Reviewed on July 4, 2026 at 12:00 p.m. ET.
CooperCompanies (ISIN US21664P1039) remains a U.S.-listed medical device group best known for its contact lens and women’s health businesses. The company trades in New York, which gives the shares a clear U.S. market anchor for retail investors.
Business model
CooperCompanies runs through two main operating lines: CooperVision and CooperSurgical. That mix ties the group to recurring demand in eye care and to procedures and products used in women’s health and fertility-related care.
Market lens
For investors, the key lens is the balance between steady consumables and more cyclical procedural demand. The stock's day-to-day tone is usually driven by earnings, guidance and margin trends rather than a single product cycle.
Go deeper
More on CooperCompanies stock
CooperCompanies is a global medtech name with a business mix that is often easier to track through segment trends than through one product headline.
Representative product line
CooperVision is the company's contact lens arm and the clearest consumer-facing part of the business. It is the segment that most directly links the company to daily-use vision care demand.
Share price and trading context
As of July 4, 2026, no verified live quote was included in this search call, so the stock context is limited to the company's listed U.S. profile. CooperCompanies shares trade on the New York Stock Exchange.
Company facts
- Company: CooperCompanies, Inc.
- ISIN: US21664P1039
- Ticker: COO
- Exchange: New York Stock Exchange
- Sector / Industry: Health Care / Medical Devices
- Next earnings date: not yet officially scheduled
This article was generated automatically and technically reviewed before publication. Market prices, analyst data and company information are provided without warranty and may change at short notice. This content is for informational purposes only and is not investment, financial, legal or tax advice. It is not a recommendation to buy or sell any security. Investing in securities involves risk, including the possible loss of principal.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
